| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| H3P23 |
|
H3 histone pseudogene 23
|
|
|
0.443 |
0.769 |
| MIR29A |
|
microRNA 29a
|
|
|
0.459 |
0.808 |
| MIR27A |
|
microRNA 27a
|
|
|
0.466 |
0.846 |
| KLRC4-KLRK1 |
P26718
|
KLRC4-KLRK1 readthrough
|
|
|
0.469 |
0.769 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR22 |
|
microRNA 22
|
|
|
0.496 |
0.808 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
| MIR19B1 |
|
microRNA 19b-1
|
|
|
0.529 |
0.769 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| MIR15B |
|
microRNA 15b
|
|
|
0.532 |
0.769 |
| UHRF1 |
Q96T88
|
ubiquitin like with PHD and ring finger domains 1
|
|
|
0.540 |
0.692 |
| CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| TEC |
|
transient erythroblastopenia of childhood
|
|
|
0.659 |
0.577 |
| BCAR4 |
|
breast cancer anti-estrogen resistance 4
|
|
|
0.653 |
0.346 |
| HPP1 |
|
hyperpigmentation, progressive, 1
|
|
|
0.686 |
0.346 |
| THM |
|
thymoma
|
|
|
0.686 |
0.500 |
| MORF4 |
|
mortality factor 4 (pseudogene)
|
|
|
0.705 |
0.423 |
| FCGR1CP |
|
Fc fragment of IgG receptor Ic, pseudogene
|
|
|
0.769 |
0.462 |
| TTN |
Q8WZ42
|
titin
|
Kinase
|
2.6E-96 |
0.470 |
0.885 |